Key result
Rilonacept data in patients with recurrent pericarditis during COVID-19 are unavailable because the article was removed at the authors' request due to lack of permissions.
Key points are not available for this paper at this time.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Trotta et al. (2022) studied this question. Rilonacept data in patients with recurrent pericarditis during COVID-19 are unavailable because the article was removed at the authors' request due to lack of permissions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: